4BIO Capital Strengthens Advisory Board and Investment Team
11 mars 2024 10h00 HE
|
4Bio Capital
Press Release 4BIO Capital Strengthens Advisory Board and Investment Team Industry veteran and former CEO of Vifor Pharma Abbas Hussain and world leading vectorology expert and LogicBio...
Development Bank of Japan invests in 4BIO Capital’s Ventures III fund
04 janv. 2024 07h00 HE
|
4Bio Capital
Press Release Development Bank of Japan invests in 4BIO Capital’s Ventures III fund 4BIO Ventures III targeting $200-300 million to unlock the treatments of the future by investing in advanced...
Development Bank of Japan invests in 4BIO Capital’s Ventures III fund
04 janv. 2024 02h00 HE
|
4Bio Capital
Press Release Development Bank of Japan invests in 4BIO Capital’s Ventures III fund 4BIO Ventures III targeting $200-300 million to unlock the treatments of the future by investing in advanced...
4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases
16 mai 2023 08h00 HE
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases Series A follows initial seed...
4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics
16 nov. 2022 08h00 HE
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics 16 November 2022 London & New York – 4BIO Capital (“4BIO” or “the Group”), an international...
4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing
07 juin 2022 08h30 HE
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Code Biotherapeutics Closes Upsized and Oversubscribed $75 Million Series A Financing 7 June 2022 London & Greater Philadelphia – 4BIO Capital...
4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics
04 janv. 2022 08h04 HE
|
4Bio Capital
Press Release 4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics 4 January 2022 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...
4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics
04 janv. 2022 08h03 HE
|
4Bio Capital
Press Release 4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics 4 January 2022 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...
4BIO Capital Announces Strategic Partnership with Harbor Capital Advisors
02 déc. 2021 09h04 HE
|
4Bio Capital
4BIO Capital Announces Strategic Partnership with Harbor Capital Advisors 4BIO Capital appointed as highly specialized asset manager for Harbor’s disruptive innovation strategy after competitive...
4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics
20 avr. 2021 09h00 HE
|
4Bio Capital
Press Release 4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics 20 April 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital...